XM does not provide services to residents of the United States of America.

Sonova launches hearing aid with real-time AI, first in market



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Sonova launches hearing aid with real-time AI, first in market</title></head><body>

By Amir Orusov and Anastasiia Kozlova

Aug 6 (Reuters) -Switzerland's Sonova SOON.S on Tuesday introduced a hearing aid that utilises real-time artificial intelligence to improve speech clarity from background noise, the first such product in the global market.

Along with the hearing aid, named Sphere Infinio, Sonova is launching a new Infinio platform.

Sonova had said in May it expected major product launches to drive sales and profit growth in the second half of its fiscal year, without providing further details.

"The launch of both new platform and product should be a surprise to the market, because nobody knew this technology and this benefit (real-time AI), which is quite significant, will be available for anyone already this year," CEO Arnd Kaldowski told Reuters in an interview.

Kaldowski reiterated that Sonova's second-half results were going to be stronger on a year-on-year basis, and confirmed its full-year outlook.

Sphere Infinio uses new DEEPSONIC chip technology that has 53 times more processing power than what is currently used by the hearing aid industry, the company said in a statement.

Sonova views Infinio and its existing Lumity platform as the main future growth drivers for its hearing instrument business, which brings in around a half of its total sales.

The hearing aid industry has been showing signs of softer market dynamics in Europe and the U.S., while analysts have also flagged tough competition in the market.

A number of hearing aid firms, including Italy's Amplifon AMPF.MI and Denmark's Demant DEMANT.CO and GN Store Nord GN.CO, have warned on profits this summer, citing volatility on the market.

"We will need to see how the market evolves and the customer reaction to the products. But we are good with our full year guidance even with the currently somewhat slower market," Kaldowski said.



Reporting by Amir Orusov and Anastasiia Kozlova in Gdansk; editing by Milla Nissi

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.